Clinical trial
A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal…
NCT00307554 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00307554 |
|---|---|
| Title | A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study |
| Official title | Assess Lot-to-lot Consistency of 3 Lots (Double Blind Design) of GlaxoSmithKline Biologicals' 10-valent Pneumococcal Vaccine and Evaluate Non-inferiority to Prevenar™ (Single Blind Design) When Administered as 3-dose Primary Immunization Course Before 6 Months of Age |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infections, Streptococcal |
| Intervention type | Biological |
| Interventions | Pneumococcal (vaccine) |
| Enrollment | 1,600 |
| Start date | Nov 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Mar 28, 2006 |
| Last update posted | Sep 26, 2016 |
| Countries | Finland, France, Poland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: